Review of the ophthalmic manifestations of gout and uric acid crystal deposition

Files

hdl_135957.pdf (1022.93 KB)
  (Submitted version)

Date

2017

Authors

Ao, J.
Goldblatt, F.
Casson, R.J.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Clinical and Experimental Ophthalmology, 2017; 45(1):73-80

Statement of Responsibility

Jack Ao, Fiona Goldblatt and Robert J Casson

Conference Name

Abstract

Gout is a clinical disorder that is characterized by the deposition of monosodium urate crystals (MSU) in joints and tendons, usually in the presence of prolonged hyperuricaemia. Following an asymptomatic phase of hyperuricaemia, gout usually presents as acute monoarthritis followed by periods of remission and exacerbation. Conjunctival hyperaemia and subconjunctival haemorrhage exacerbated by purine intake are two of the more common manifestations that may go unrecognized. Other ocular and adnexal structures can be affected by urate crystal deposition and associated inflammation, with potentially vision-threatening consequences; however, ocular manifestations of gout are rare and may have been over-reported in the older literature, but our understanding of the clinic-pathological features of ocular urate deposits remains limited.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2016 Royal Australian and New Zealand College of Ophthalmologists

License

Grant ID

Call number

Persistent link to this record